Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Peptide-siRNA nanotherapeutics in arthritis.

Pham CT, Pan H, Wickline SA.

Oncotarget. 2015 Jun 20;6(17):14731-2. No abstract available.

2.

Recent advances in siRNA delivery.

Sarisozen C, Salzano G, Torchilin VP.

Biomol Concepts. 2015 Dec;6(5-6):321-41. doi: 10.1515/bmc-2015-0019. Review.

PMID:
26609865
3.

Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.

De Backer L, Cerrada A, Pérez-Gil J, De Smedt SC, Raemdonck K.

J Control Release. 2015 Dec 28;220(Pt B):642-50. doi: 10.1016/j.jconrel.2015.09.004. Epub 2015 Sep 10. Review.

PMID:
26363301
4.

Budding Alliance of Nanotechnology in RNA Interference Therapeutics.

Kumawat A, Dapse P, Kumar N, Mishra DK, Maheshwari R, Bhattacharya P, Tekade RK.

Curr Pharm Des. 2018;24(23):2632-2643. doi: 10.2174/1381612824666180807113948. Review.

PMID:
30084328
5.
6.

Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis.

Zhou HF, Yan H, Pan H, Hou KK, Akk A, Springer LE, Hu Y, Allen JS, Wickline SA, Pham CT.

J Clin Invest. 2014 Oct;124(10):4363-74. doi: 10.1172/JCI75673. Epub 2014 Aug 26.

7.

Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines.

Deshayes S, Konate K, Rydström A, Crombez L, Godefroy C, Milhiet PE, Thomas A, Brasseur R, Aldrian G, Heitz F, Muñoz-Morris MA, Devoisselle JM, Divita G.

Small. 2012 Jul 23;8(14):2184-8. doi: 10.1002/smll.201102413. Epub 2012 Apr 18. No abstract available.

PMID:
22514050
8.

Strategies and advances in nanomedicine for targeted siRNA delivery.

Nimesh S, Gupta N, Chandra R.

Nanomedicine (Lond). 2011 Jun;6(4):729-46. doi: 10.2217/nnm.11.15.

PMID:
21718181
9.

Genetic pharmacology: progresses in siRNA delivery and therapeutic applications.

Scherman D, Rousseau A, Bigey P, Escriou V.

Gene Ther. 2017 Mar;24(3):151-156. doi: 10.1038/gt.2017.6. Epub 2017 Jan 25. Review.

PMID:
28121307
10.

Peptide-Aptamer Coassembly Nanocarrier for Cancer Therapy.

Ma Y, Li W, Zhou Z, Qin X, Wang D, Gao Y, Yu Z, Yin F, Li Z.

Bioconjug Chem. 2019 Mar 20;30(3):536-540. doi: 10.1021/acs.bioconjchem.8b00903. Epub 2019 Feb 7.

PMID:
30702869
11.

Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy.

Kim YD, Park TE, Singh B, Maharjan S, Choi YJ, Choung PH, Arote RB, Cho CS.

Nanomedicine (Lond). 2015;10(7):1165-88. doi: 10.2217/nnm.14.214. Review.

PMID:
25929572
12.

Macrophage-mediated nanoparticle delivery to the periodontal lesions in established murine model via Pg-LPS induction.

Ma Z, Dagnaes-Hansen F, Løvschall H, Song W, Nielsen GK, Yang C, Wang Q, Kjems J, Gao S.

J Oral Pathol Med. 2015 Aug;44(7):538-42. doi: 10.1111/jop.12269. Epub 2014 Sep 25.

PMID:
25258036
13.

Tackling breast cancer chemoresistance with nano-formulated siRNA.

Jones SK, Merkel OM.

Gene Ther. 2016 Dec;23(12):821-828. doi: 10.1038/gt.2016.67. Epub 2016 Sep 20. Review.

14.

RNAi therapeutics: the teenage years.

Perkel JM.

Biotechniques. 2012 Jun;52(6):355-7. doi: 10.2144/000113871. No abstract available.

15.

Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review.

Taymouri S, Taheri A.

Curr Drug Deliv. 2016;13(5):662-72. Review.

PMID:
26343151
16.

Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

Zhao J, Feng SS.

Nanomedicine (Lond). 2015 Jul;10(14):2199-228. doi: 10.2217/nnm.15.61. Review.

PMID:
26214357
17.

Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.

Wagner A, Bock CT, Fechner H, Kurreck J.

Future Med Chem. 2015;7(13):1637-42. doi: 10.4155/fmc.15.114. Epub 2015 Sep 18. No abstract available.

PMID:
26381598
18.

Nanooncology in ovarian cancer treatment.

Kasprzak B, Miskiel S, Markowska J.

Eur J Gynaecol Oncol. 2016;37(2):161-3. Review.

PMID:
27172737
19.

Synthesis, Physicochemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma.

Tommasini-Ghelfi S, Lee A, Mirkin CA, Stegh AH.

Methods Mol Biol. 2019;1974:371-391. doi: 10.1007/978-1-4939-9220-1_25.

PMID:
31099015
20.

Multifunctional Oligoaminoamides for the Receptor-Specific Delivery of Therapeutic RNA.

Weber J, Lächelt U, Wagner E.

Methods Mol Biol. 2015;1324:369-86. doi: 10.1007/978-1-4939-2806-4_25.

PMID:
26202283

Supplemental Content

Support Center